ReviewPLoS medicine2017
malERA: An updated research agenda for malaria elimination and eradication.
Review in PLoS medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
137 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Targeted Test and Treat at Point of Entry to Reduce Importation of Malaria Parasites: A Systematic Review.The American journal of tropical medicine and hygiene · 2024Pooled it
- Evaluation of the malaria elimination policy in Brazil: a systematic review and epidemiological analysis study.Tropical biomedicine · 2020Pooled it
- A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.BMC medicine · 2024Trial
- Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Trial
- Proactive community case management decreased malaria prevalence in rural Madagascar: results from a cluster randomized trial.BMC medicine · 2022Trial
- A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria Infection.The Journal of infectious diseases · 2021Trial
- School-based screening and treatment may reduce P. falciparum transmission.Scientific reports · 2021Trial
- A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.The Journal of infectious diseases · 2020Trial
- Prevalence ofPathogens (Basel, Switzerland) · 2026Article
- Application Strategy and Research Progress of Large-Scale Population Drug Intervention in Malaria Control.Tropical medicine and infectious disease · 2026Review
- Simian iPS-derived hepatocytes supportFrontiers in cellular and infection microbiology · 2026Article
- Challenges in sustaining the elimination of visceral leishmaniasis in India.International health · 2025Article
- An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.Nature communications · 2025Article
- An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters.Malaria journal · 2025Review
- China's Malaria R&D Innovations: A Scoping Review from 2013-2023.China CDC weekly · 2025Article
- Simulating dynamic insecticide selection pressures for resistance management in mosquitoes assuming polygenic resistance.PLoS computational biology · 2025Article
- Observational
- Population genetics ofFrontiers in genetics · 2025Article
- Malaria and missed school days: exploring school absenteeism patterns and local strategies in Odisha, India.Frontiers in public health · 2025Article
- Examining malaria treatment and prevention spending efficiency in malaria-endemic countries, 2000-2020.Malaria journal · 2024Article
77 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Achieving a malaria-free world presents exciting scientific challenges as well as overwhelming health, equity, and economic benefits. WHO and countries are setting ambitious goals for reducing the burden and eliminating malaria through the "Global Technical Strategy" and 21 countries are aiming to eliminate malaria by 2020. The commitment to achieve these targets should be celebrated. However, the need for innovation to achieve these goals, sustain elimination, and free the world of malaria is greater than ever. Over 180 experts across multiple disciplines are engaged in the Malaria Eradication Research Agenda (malERA) Refresh process to address problems that need to be solved. The result is a research and development agenda to accelerate malaria elimination and, in the longer term, transform the malaria community's ability to eradicate it globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.